Forbes

A rare inherited EGFR mutation raises lung cancer odds 25-fold overall and more than 60-fold in never-smokers, revealing why some nonsmokers develop lung cancer.

With Medicare Advantage premiums to drop by 16% in 2027, this could further boost the percentage of seniors and disabled folks who choose the privately run alternative.

Anthropic is pushing Claude into prior authorization, medical records, drug discovery and global health. A physician explains what it means for doctors and patients.

New York Knicks center Karl-Anthony Towns has had a good 2026 with his marriage and NBA Championship. 2020 was far different with the loss of his mom to COVID-19.

A new book from former Biden official Raj Panjabi unpacks the notion of “normalcy bias.” It may help explain how we have come to accept our country’s underperforming healthcare system.

Hundreds of cases and one death have been reported in Florida from dengue fever. A doctor breaks down symptoms to watch for and how to prevent it.

A test of 511 AI-designed antibodies shows AI can improve promising drug candidates, but lab experiments remain essential for discovering safe, developable antibodies.

A conversation with two leading neurologists share actionable insights on proactive baselining, lifestyle rigor, and sensory health to protect cognitive function.

Marketed for over a decade as a natural wellness product, kratom contains mitragynine and its derivative 7-hydroxymitragynine, which both interact with opioid receptors.

Cornell’s sexual assault allegations echo a case from 41 years ago, exposing how little has changed in who bears the consequences when campus systems fail.

Sexual assault can affect physical and mental health for months or years. Here’s what survivors may face—and what good healthcare should provide.

While Pharmacy First could partially relieve wait times at GP offices and emergency rooms, it’s sidestepping the larger chronic problem of NHS underfunding.

The question becomes whether firms will respond by withdrawing drugs from certain markets or delaying launches of their newly approved drugs in these jurisdictions.

As Breast Cancer Awareness Month begins, women diagnosed today benefit from decades of progress in care. However, innovation does not automatically create health equity.

Emicizumab, a bispecific antibody that bridges clotting factors IX and X, restores factor VIII function and prevents bleeding in hemophilia A with infrequent injections.